Form D · Biotechnology

Legend Biotech Corp

Somerset, NJ · CIK 0001801198

Offering snapshot reported Apr 28, 2023 · SEC filing

Reported sold
$200M
Offering amount: $200M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 19, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2023Initial$200,000,005No comparison1SEC filing
Apr 7, 2020Initial$150,450,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-480374
The exact Total Offering Amount and Total Amount Sold is US$200,000,004.16, respectively, each rounded to $200,000,005 for purposes of reporting on Form D.

Source: Form D, filed Apr 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick Casey, Ph.D. Director
Tomas Heyman Director
Ying Huang, Ph.D. Director, Executive
Darren Xiaohui Ji, M.D., Ph.D. Director
Lori Macomber Executive
Li Mao, Md Director
Corazon D. Sanders, Ph.D. Director
Ye Wang, M.S. Director
Yuan Xu, Ph.D. Director, Executive
Philip Wai Man Yau, Cpa Director
Fangliang Zhang, Ph.D. Director
Li Zhu, Ph.D. Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2101 Cottontail Lane
Somerset, NJ, 08873